Invesaro

Stocks AYRWF Financial statements

Financial statements

Ayr Wellness Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Ayr Wellness Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2020FY2020FY2021FY2022FY2023FY2024
Revenue75.2155358466464464
Cost of revenue40.866.6246261287
Gross profit26.388.8138175202177
Selling, general and administrative144213178167
Selling and marketing1.352.157.7
Operating expenses382240338
Operating income-37.51.23-56-207-37.1-161
Interest expense28.339.478.3
Other non-operating income35.2-8.63-158
Pre-tax income-159-2.5212.3-172-45.8-319
Income tax4.8422.129.344.747.443.3
Net income to minority interests-10-7.07-3.05
Net income-164-24.6-17-245-272-359
EBITDA-188-4.82-133
EPS, basic-1.31-0.88-0.30-3.58-3.68-3.24
EPS, diluted-1.31-0.88-0.30-3.58-3.68-3.24
Shares, basic (weighted)0.070.070.11
Shares, diluted (weighted)0.070.070.11

Balance sheet

FY2020FY2020FY2021FY2022FY2023FY2024
Cash and equivalents8.412715076.850.835.5
Receivables7.7413.513.2
Inventory13.722.993.499.8106113
Total current assets29.9159266454209175
Property, plant and equipment37.269.1275303310278
Lease right-of-use assets12.322.6121126164
Goodwill54.95819994.194.10
Intangible assets190252979745674617
Total assets3555651,8601,7681,4601,269
Accounts payable26.72430.9
Accrued liabilities25.540.827
Short-term debt40.523.224.8
Total current liabilities34.757.5152269201109
Long-term debt136411386
Lease liabilities1323.9118125180
Other non-current liabilities0.522522
Total liabilities187280840932889904
Total debt177434410
Paid-in capital28.9601,3501,3711,519
Retained earnings-246-248-265-511-783-1,142
Treasury stock-8.99-8.990
Other comprehensive income3.273.273.27
Shareholders' equity1,020833582380
Minority interests0002-11.1-14.7
Total equity2002851,020835571365
Total liabilities and equity3555651,8601,7681,4601,269

Cash flow statement

FY2020FY2020FY2021FY2022FY2023FY2024
Net income-164-24.6-17-255-280-362
Depreciation and amortization1932.328.2
Stock-based compensation16.418
Deferred income tax1.59-7.45-14.2
Change in receivables0.06-6.05-0.74
Change in inventory-12.5-6.25-6.76
Cash from operations-34.227.29.63
Capital expenditures-14.4-14.4-91.6-58.8-27.7-17.7
Cash from investing5.24-62.2-220-66.5-24.2-21.8
Debt issued10414951.710.740
Debt repaid-2.88-5.62-8.75-17.9-52-22.2
Stock issued1180.3
Share buybacks-8.43
Cash from financing-1.514627527-32.9-3.1
Exchange rate effect0.98
Net change in cash-73.7-29.9-15.3
Free cash flow-93-0.53-8.08
Interest paid49.249.958.3
Income taxes paid30.97.086.41

Key metrics

Worked out from the statements above. Latest values use fiscal 2024. Valuation uses the share price of $0.00 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin38.1%Gross profit / revenue.
Operating margin-34.7%Operating income / revenue.
EBITDA margin-28.6%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-68.8%Pre-tax income / revenue.
Net margin-77.5%Net income / revenue.
FCF margin-1.7%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin2.1%Cash from operations / revenue.
Return on equity (ROE)-74.8%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-26.3%Net income / average total assets.
Return on invested capital (ROIC)-14.8%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue36.0%Selling, general and administrative expense / revenue.
Stock-based pay / revenue3.9%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue3.8%Capital expenditures / revenue.
D&A / revenue6.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y0.0%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y9.0%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y43.9%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-12.7%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y8.6%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y46.4%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-64.5%Operating cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y-34.8%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-28.1%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y-13.1%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-12.0%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y29.0%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y49.6%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.60xCurrent assets / current liabilities.
Quick ratio0.45x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.32x(Cash + short-term investments) / current liabilities.
Debt / equity1.08xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets32.3%Total debt / total assets.
Liabilities / assets71.3%Total liabilities / total assets.
Net debt$375.0MTotal debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage-2.06xOperating income / interest expense.
Working capital$65.8MCurrent assets - current liabilities.
Goodwill and intangibles / assets48.6%(Goodwill + intangible assets) / total assets.
Tangible book value-$237.1MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.34xRevenue / average total assets.
Fixed asset turnover1.58xRevenue / average property, plant and equipment.
Inventory turnover2.62xCost of revenue / average inventory.
Days inventory139 days365 x average inventory / cost of revenue.
Receivables turnover34.7xRevenue / average receivables.
Days sales outstanding11 days365 x average receivables / revenue.
Days payables35 days365 x average accounts payable / cost of revenue.
Cash conversion cycle115 daysDays inventory + days sales outstanding - days payables.
Capex / operating cash flow183.9%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted-$3.24Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic-$3.24Net income per basic share, as reported (split-adjusted).
Revenue per share$4,183.00Revenue / diluted weighted shares.
FCF per share-$72.94Free cash flow / diluted weighted shares.
Operating cash flow per share$86.91Cash from operations / diluted weighted shares.
Book value per share$3,424.00Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$2,140.00Tangible book value / shares outstanding.
Cash per share$320.14(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$402.4KShare price x shares outstanding.
Enterprise value$375.4MMarket cap + total debt - cash - short-term investments.
P/S0.00xMarket cap / revenue.
P/B0.00xMarket cap / shareholders' equity. Only when equity is positive.
P/OCF0.04xMarket cap / cash from operations, when positive.
EV/Sales0.81xEnterprise value / revenue.
FCF yield-2,009.0%Free cash flow / market cap.
Earnings yield-89,289.0%Net income / market cap (the inverse of P/E).
What was Ayr Wellness Inc.'s revenue in fiscal 2024?

Ayr Wellness Inc. reported revenue of $463.6M for fiscal 2024, 0% higher than the year before.

Was Ayr Wellness Inc. profitable in fiscal 2024?

No. It reported a net loss of $359.3M.

How much free cash flow did Ayr Wellness Inc. generate in fiscal 2024?

Cash from operations of $9.6M minus capital expenditures of $17.7M left free cash flow of -$8.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Ayr Wellness Inc.